MariMed Inc. announced that its stockholders approved a proposal allowing the Board to implement a reverse stock split of the company's common stock at a ratio between 1-for-50 and 1-for-100. The Board will decide if and when to execute the split based on market conditions and potential listing requirements on a U.S. national securities exchange. The reverse split aims to reduce the number of outstanding shares without changing stockholders' proportional ownership, except for fractional share adjustments. However, there is no guarantee the split will be implemented or that it will improve the stock's trading price or liquidity.
MariMed Inc. stockholders approved a reverse stock split proposal. For readers following Consumer Cyclical stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:42 WIB: 84 of 134 US Consumer Cyclical stocks rose, 40 fell. Notable movers include RENT at USD 2.52 (-6.32%), EBAY at USD 125.39 (+6.24%), and NCLH at USD 16.97 (+5.67%).
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
